Page last updated: 2024-10-31

metolazone and Obesity

metolazone has been researched along with Obesity in 2 studies

Metolazone: A quinazoline-sulfonamide derived DIURETIC that functions by inhibiting SODIUM CHLORIDE SYMPORTERS.
metolazone : A quinazoline that consists of 1,2,3,4-tetrahydroquinazolin-4-one bearing additional methyl, 2-tolyl, sulfamyl and chloro substituents at positions 2, 3, 6 and 7 respectively. A quinazoline diuretic, with properties similar to thiazide diuretics.

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arosio, E1
Pancera, P1
Apolloni, E1
Covi, G1
Lechi, A1
Truniger, B1

Other Studies

2 other studies available for metolazone and Obesity

ArticleYear
[Clinical evaluation of metolazone in edematogenic syndromes].
    La Clinica terapeutica, 1984, Dec-15, Volume: 111, Issue:5

    Topics: Adult; Aged; Coronary Disease; Diuretics; Edema; Female; Heart Failure; Heart Valve Diseases; Humans

1984
[Therapy edema: secondary effect without effect!].
    Schweizerische medizinische Wochenschrift, 1999, Nov-20, Volume: 129, Issue:46

    Topics: Adult; Anuria; Diuretics; Edema; Female; Furosemide; Humans; Lymphedema; Metolazone; Obesity

1999